ReachMD
ReachMD CME
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.
Vizitează neapărat site-ul podcastului și susține-i creatorul: reachmd.com
Unde asculți?
Podcasturi în aplicație Replaio Radio În curândPodcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor
Episoade
Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer 14.11.2025 5:30
CME credits: 0.50 Valid until: 14-11-2026 Claim your CME credit at https://reachmd.com/programs/cme/navigating-the-therapeutic-landscape-of-platinum-resistant-ovarian-cancer/37667/ Platinum-resistant ovarian cancer remains a major clinical challenge, characterized by high recurrence rates, limited durable treatment options, and poor overall survival outcomes. Cadherin-6 (CDH6)-targeted antibody-dr...
The Fifth Pillar? Closing the Gap in HFrEF 14.11.2025 29:30
CME credits: 0.50 Valid until: 14-11-2026 Claim your CME credit at https://reachmd.com/programs/cme/the-fifth-pillar-closing-the-gap-in-hfref/37615/ For patients with heart failure with reduced ejection fraction (HFrEF), optimizing therapy is an important part of treatment and care. But not all patients may be reaching their treatment goals and can continue to face substantial residual risk despit...
Advancing gMG Clinical Decisions: Diagnosing Early, Treating Smarter, and Caring Holistically – A Case-Based Treatment Approach 13.11.2025 16:30
CME credits: 0.25 Valid until: 15-11-2026 Claim your CME credit at https://reachmd.com/programs/cme/advancing-gmg-clinical-decisions-diagnosing-early-treating-smarter-and-caring-holistically-a-case-based-treatment-approach/36276/ This case-based discussion follows Maria, a 38-year-old teacher presenting with fluctuating ptosis, diplopia, and fatigue—classic but easily overlooked signs of generaliz...
Treating MASH With Compensated Cirrhosis: A Serious Unmet Need 11.11.2025 16:15
CME credits: 0.25 Valid until: 11-11-2026 Claim your CME credit at https://reachmd.com/programs/cme/treating-mash-with-compensated-cirrhosis-a-serious-unmet-need/37646/ Metabolic dysfunction-associated steatohepatitis (MASH) with compensated cirrhosis is associated with poor prognosis due to a high risk of hepatic decompensation, hepatocellular carcinoma, cardiovascular events, and death. Using no...
Advancing Clinical Expertise in CELMoDs: Transforming Multiple Myeloma Treatment 10.11.2025 42:00
CME credits: 1.00 Valid until: 10-11-2026 Claim your CME credit at https://reachmd.com/programs/cme/advancing-clinical-expertise-in-celmods-transforming-multiple-myeloma-treatment/35631/ This activity will cultivate familiarity with the emerging CELMoD treatment class poised to transform the management of newly-diagnosed and R/R MM. With a higher affinity for cereblon than their predecessors, CELM...
Optimizing the Role for Corticosteroids Within the Evolving DMD Treatment Landscape 07.11.2025 43:00
CME credits: 1.00 Valid until: 07-11-2026 Claim your CME credit at https://reachmd.com/programs/cme/optimizing-the-role-for-corticosteroids-within-the-evolving-dmd-treatment-landscape/37232/ Corticosteroids remain a cornerstone in Duchenne muscular dystrophy (DMD) management, but evolving therapies demand a more nuanced approach. This case-based activity explores how to proactively monitor and man...
Updates in Major Depressive Disorder with Insomnia 07.11.2025 26:30
CME credits: 0.50 Valid until: 07-11-2026 Claim your CME credit at https://reachmd.com/programs/cme/updates-in-major-depressive-disorder-with-insomnia/36556/ Approximately 75% to 90% of patients with depression experience insomnia. This means that a very significant portion of individuals struggling with depression also have difficulty sleeping. Join Drs. Michael Thase and Andrew Krystal for this...
The Hidden Threat: Transforming CKD Care Across the Diabetes Spectrum 05.11.2025 22:30
CME credits: 0.50 Valid until: 05-11-2026 Claim your CME credit at https://reachmd.com/programs/cme/the-hidden-threat-transforming-ckd-care-across-the-diabetes-spectrum/36523/ Chronic kidney disease (CKD) is a common complication in type 2 diabetes that is closely linked to cardiovascular risk and often diagnosed late. Early detection with UACR and eGFR, plus treatment with therapies such as SGLT2...
From Pain to Possibilities: Safe Opioid Use and Treatment of Patients with Pain 01.11.2025 1:49:30
CME credits: 2.00 Valid until: 31-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/from-pain-to-possibilities-safe-opioid-use-and-treatment-of-patients-with-pain/56432/ This Opioid Analgesic REMS webcast provides an FDA Blueprint-aligned learning experience to support safe, compassionate pain management through thorough assessment and individualized treatment planning. Also covere...
Breaking the Cycle: Prioritizing Weight Loss to Improve OSA Management 31.10.2025 45:15
CME credits: 1.00 Valid until: 30-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/breaking-the-cycle-prioritizing-weight-loss-to-improve-osa-management/48715/ On-demand webcast of expert faculty presentation on the connection between obstructive sleep apnea (OSA) and obesity, including strategies for prioritizing weight loss to improve OSA management among select patients. =
Case Applications in Multidisciplinary Care for Endometrial Cancer 31.10.2025 5:45
CME credits: 1.00 Valid until: 31-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/Case-Applications-in-Multidisciplinary-Care-for-Endometrial-Cancer/39298/ This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biomarker testin...
Applications in Multidisciplinary Care for Cervical Cancer 31.10.2025 5:45
CME credits: 1.00 Valid until: 31-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/Applications-in-Multidisciplinary-Care-for-Cervical-Cancer/39297/ This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biomarker testing, clini...
Managing Immune-Related Adverse Events in Cervical and Endometrial Cancer 31.10.2025 5:45
CME credits: 1.00 Valid until: 31-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/Managing-Immune-Related-Adverse-Events-in-Cervical-and-Endometrial-Cancer/39296/ This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biomarker...
Evidence Base for Treatment Strategies for Endometrial Cancer After Disease Progression and Interdisciplinary Collaboration 31.10.2025 5:15
CME credits: 1.00 Valid until: 31-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/Evidence-Base-for-Treatment-Strategies-for-Endometrial-Cancer-After-Disease-Progression-and-Interdisciplinary-Collaboration/39295/ This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and perso...
Evidence Base for First-Line Treatment Strategies for Endometrial Cancer and Delivering Guideline-Concordant Care 31.10.2025 5:15
CME credits: 1.00 Valid until: 31-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/Evidence-Base-for-First-Line-Treatment-Strategies-for-Endometrial-Cancer-and-Delivering-Guideline-Concordant-Care/39294/ This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized ca...
Role of Predictive Biomarkers in Endometrial Cancer 31.10.2025 5:15
CME credits: 1.00 Valid until: 31-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/Role-of-Predictive-Biomarkers-in-Endometrial-Cancer/39293/ This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biomarker testing, clinical tri...
Evidence- and Guideline-Based Treatment for Advanced/Metastatic Cervical Cancer 31.10.2025 4:15
CME credits: 1.00 Valid until: 31-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/Evidence-and-Guideline-Based-Treatment-for-Advanced-Metastatic-Cervical-Cancer/39292/ This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biom...
Screening for Cervical Cancer 31.10.2025 5:45
CME credits: 1.00 Valid until: 31-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/Screening-for-Cervical-Cancer/39290/ This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biomarker testing, clinical trial evidence, and the i...
Interdisciplinary Management of Gynecologic Cancers 31.10.2025 5:30
CME credits: 1.00 Valid until: 31-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/Interdisciplinary-Management-of-Gynecologic-Cancers/39286/ This series features interdisciplinary discussions on the evolving management of cervical and endometrial cancers, emphasizing biomarker-driven decision-making and personalized care. Experts examine screening, biomarker testing, clinical tri...
Case-Based Approach: Optimizing Cardio-Kidney-Metabolic Outcomes in Individuals With T2D & CKD 31.10.2025 17:30
CME credits: 0.25 Valid until: 31-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/case-based-approach-optimizing-cardio-kidney-metabolic-outcomes-in-individuals-with-t2d-ckd/29906/ This case-based program explores the missed opportunities in CKD detection and treatment in a patient with type 2 diabetes. Drs. Agarwal and Cos emphasize the role of primary care physicians in annual...
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia 30.10.2025 14:15
CME credits: 0.25 Valid until: 30-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/are-all-vmat2s-the-same-data-driven-treatment-decisions-for-tardive-dyskinesia/36174/ Tardive Dyskinesia (TD) is an involuntary movement disorder that can develop as a side effect of taking antipsychotic and other medications. Currently there are 2 FDA approved VMAT2 inhibitors for treating TD. Join...
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology 29.10.2025 32:30
CME credits: 0.50 Valid until: 29-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/mechanism-driven-gmg-therapy-fcrn-antagonists-and-the-rise-of-precision-neurology/36277/ This Clinical Countdown addresses key challenges in diagnosing and managing generalized myasthenia gravis (gMG), with a focus on FcRn antagonists. Drs. Edmundson and Goyal review diagnostic challenges in gMG, al...
The Patient-Clinician Connection in Managing CKD-aP 24.10.2025 7:30
CME credits: 1.00 Valid until: 24-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/the-patient-clinician-connection-in-managing-ckd-ap/36302/ Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology,...
Improving Sleep and Mental Health in Patients with CKD-aP 24.10.2025 4:30
CME credits: 1.00 Valid until: 24-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/improving-sleep-and-mental-health-in-patients-with-ckd-ap/36301/ Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etio...
Kappa-Opioid Settings: Real-World Evidence Insights 24.10.2025 4:45
CME credits: 1.00 Valid until: 24-10-2026 Claim your CME credit at https://reachmd.com/programs/cme/kappa-opioid-settings-real-world-evidence-insights/36300/ Despite its prevalence, chronic kidney disease–associated pruritus (CKD-aP) remains underrecognized and undertreated in patients undergoing hemodialysis, owing to its complex pathophysiology, diagnostic challenges, symptom cluster etiology, a...
Podcasturi asemănătoare
Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice